You just read:

MPM Capital and Versant Ventures Launch CODA Biotherapeutics to Accelerate Development of Chemogenetic Gene Therapy Platform

News provided by

CODA Biotherapeutics, Inc.

Sep 12, 2018, 09:00 ET